COMPOSITION FOR ORAL DELIVERY COMPRISING MGBG FOR USE IN TREATING MULTIPLE SCLEROSIS
申请人:Pathologica LLC
公开号:EP3473247A1
公开(公告)日:2019-04-24
The present invention relates to an oral pharmaceutical composition, comprising methylglyoxal bis(guanylhydrazone) (MGBG) together with at least one oral pharmaceutically acceptable excipient, for use in the treatment or delaying the onset or development of multiple sclerosis when orally administered to a subject.
本发明涉及一种口服药物组合物,包括甲基乙二醛双(鸟苷腙)(MGBG)和至少一种口服药物可接受赋形剂,用于口服给受试者治疗或延缓多发性硬化症的发作或发展。